Skip to main content
. Author manuscript; available in PMC: 2021 Jan 6.
Published in final edited form as: J Opioid Manag. 2019 Nov-Dec;15(6):445–453. doi: 10.5055/jom.2019.0535
Risk stratification Recommended monitoring
Standard risk
  • Baseline for everyone who receives chronic opioid medication from our practice

Baseline for everyone:
  • Quarterly office visits

  • Contract yearly

  • UDS every 6 months

  • PMP with every prescription

  • If new to practice, consent to obtain medical records from past provider

Moderate risk
  • Request for increase in pain meds

  • Nonadherence to adjunctive therapy (PT, exercise, pain/rehabilitation medicine appointments)

  • One lost or stolen script/damaged pills

  • Personal history of substance abuse

  • Daily dose greater than or equal to 90 mg morphine equivalents

In addition to baseline:
  • UDS every 4 months

Other suggestions:
  • Discussion regarding pain management goals and review of opioid agreement

  • Consider referral to Pain Clinic or Rehabilitation Medicine

High risk
  • Nonadherence to monitoring guidelines—refusal to leave urine, not meeting minimal office visit requirements (canceling appointments)

  • Multiple lost or stolen scripts/damaged pills

  • Taking medication differently than prescribed resulting in request for another prescription early

  • Multiple ED visits

  • Concomitant use of benzodiazepines

  • UDS negative for prescribed medications

  • UDS positive for “other” substances

In addition to baseline:
  • Monthly or every other month office visits

  • UDS every 3 months—consider true random testing

Other suggestions:
  • Discussion regarding pain management goals and review of opioid agreement

  • Consider 14-day prescription schedule

  • Loss of privilege to pick up scripts early

High consideration to an individualized treatment plan, may include:
  • Random UDS or pill checks

  • UDS and PMP checks with every prescription

  • Weekly or q 14 day prescription schedule; possibility of lengthening schedule thereafter

  • Adjunctive therapies including pain clinic, rehabilitation medicine, social work, or drug counseling referrals

  • Possible termination

Termination
  • PMP confirms receipt of narcotics from multiple non-ED providers

  • Confirmed illegal activity—selling/diverting pills, forging scripts

  • Overdose on opioid or illegal substances

  • Noncompliant to individualized treatment plan

  • Termination of opioid prescribing/1 month taper

  • Substance abuse program

  • Weaning protocol

Abbreviations: ED, emergency department; PT, physical therapy; PMP, prescription monitoring program; UDS, urine drug screen.